Abstract 3468: Aberrant activation of gli1 and notch1 contributes to racial disparity in triple negative breast cancer progression

Racial Disparity ◽

Triple Negative ◽

Abstract LB-222: Aberrant activation of GLI1 and Notch1 contributes to racial disparity in triple-negative breast cancer progression

10.1158/1538-7445.am2020-lb-222 ◽

2020 ◽

Author(s):

Sumit Siddharth ◽

Anirudh Saxena ◽

Nethaji Muniraj ◽

Sheetal Parida ◽

Arumugam Nagalingam ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Progression ◽

Racial Disparity ◽

Triple Negative ◽

Abstract 3468: Aberrant activation of gli1 and notch1 contributes to racial disparity in triple negative breast cancer progression

10.1158/1538-7445.am2019-3468 ◽

2019 ◽

Author(s):

Sumit Siddharth ◽

Nethaji Muniraj ◽

Sheetal Parida ◽

Arumugam Nagalingam ◽

Dipali Sharma

Keyword(s):

Breast Cancer ◽

Cancer Progression ◽

Racial Disparity ◽

Triple Negative ◽

Circ_0000520 contributes to triple‐negative breast cancer progression through mediating the miR‐1296/ZFX axis

Thoracic Cancer ◽

10.1111/1759-7714.14085 ◽

2021 ◽

Author(s):

Yong Zhou ◽

Guoxi Ma ◽

Shijun Peng ◽

Min Tuo ◽

Yinmou Li ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Progression ◽

Triple Negative ◽

RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA

Oncogene ◽

10.1038/s41388-021-02030-x ◽

2021 ◽

Author(s):

C. James Block ◽

Allison V. Mitchell ◽

Ling Wu ◽

James Glassbrook ◽

Douglas Craig ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Progression ◽

Triple Negative ◽

Rna Binding ◽

Binding Protein ◽

Rna Binding Protein ◽

Regulatory T cells: Their role in triple‐negative breast cancer progression and metastasis

Cancer ◽

10.1002/cncr.34084 ◽

2022 ◽

Author(s):

Rama Rao Malla ◽

Padmaraju Vasudevaraju ◽

Rahul Kumar Vempati ◽

Marni Rakshmitha ◽

Neha Merchant ◽

...

Keyword(s):

Breast Cancer ◽

T Cells ◽

Regulatory T Cells ◽

Cancer Progression ◽

Triple Negative ◽

Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187

Oncogenesis ◽

10.1038/s41389-020-0220-5 ◽

2020 ◽

Vol 9 (3) ◽

Author(s):

Zhonghao Wang ◽

Qiong Kong ◽

Peng Su ◽

Miao Duan ◽

Min Xue ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Progression ◽

Ubiquitin Ligase ◽

Triple Negative ◽

Breast Cancer Progression ◽

Hippo Signaling

miR-744/eNOS/NO axis: A novel target to halt triple negative breast cancer progression

European Journal of Cancer ◽

10.1016/s0959-8049(18)30623-3 ◽

2018 ◽

Vol 92 ◽

pp. S133

Author(s):

F. El-Kilany ◽

R.A. Youness ◽

R.A. Assal ◽

M.Z. Gad

Keyword(s):

Breast Cancer ◽

Cancer Progression ◽

Triple Negative ◽

Breast Cancer Progression ◽

Novel Target

Abstract 5079: Inhibition of HDAC2, but not HDAC1, abrogates triple negative breast cancer progression and metastasis

10.1158/1538-7445.am2017-5079 ◽

2017 ◽

Author(s):

Hope E. Burks ◽

Steven Elliott ◽

Van T. Hoang ◽

Margarite D. Matossian ◽

Bridgette Collins Burow ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Progression ◽

Triple Negative ◽

Abstract LB-183: Anti-PD1 blunts obesity associated triple negative breast cancer progression

10.1158/1538-7445.sabcs18-lb-183 ◽

2019 ◽

Author(s):

Ajeeth Pingili ◽

Emily Miller ◽

Bin Teng ◽

Liza Makowski

Keyword(s):

Breast Cancer ◽

Cancer Progression ◽

Triple Negative ◽

Abstract B50: The role of CXCL13-CXCR5 signaling in triple-negative breast cancer progression

10.1158/1538-7755.disp17-b50 ◽

2018 ◽

Author(s):

Courtney D. Dill ◽

Adaugo Okoro ◽

Dongquan Chen ◽

James W. Lillard

Keyword(s):

Breast Cancer ◽

Cancer Progression ◽

Triple Negative ◽